Paul Anthony Brennan

This profile gathers the share dealings of Paul Anthony Brennan in NervGen Pharma Corp. Over a trading history stretching from 26 November 2019 to 4 May 2022, the count stands at 4 filings.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

The record was last updated on 5 May 2022 with an option exercise (€59k) in NervGen Pharma Corp. Filings reach the SEDI feed a median of 2 days after the trade. Until a filing is published, the market cannot know about the trade. Source: insider filings from SEDI. Past trades are no guide to future returns.